The Valley Desk

ReviewJournal of the American Heart AssociationPublished

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Journal of the American Heart Association
Published
Subject terms
Humans; Cardiomyopathy, Hypertrophic; Benzylamines; Uracil; Echocardiography; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Dose-Response Relationship, Drug; Cytochrome P-450 CYP2C19; Left ventricular ejection fraction; Echocardiogram
PubMed ID
39206723
PubMed Central ID
PMC11646538
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal